Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer Surgery
NCT07690462 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2026-07-08
Summary
This study aims to validate the accuracy of the infrared fluorescence rapid detection technique for the diagnosis of prostate biopsy specimens, and to compare it with intraoperative frozen section and conventional paraffin section (the gold standard), so as to evaluate its feasibility and value in clinical application.
Conditions
Sponsors & Collaborators
-
Xiangya Hospital of Central South University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
NCT06684652 ·Status: RECRUITING ·Phase: NA
-
Radioactive Counts From PSMA PET/CT-Targeted Biopsy Specimens for Real-time Diagnosis of Prostate Cancer: A Prospective Study
NCT07709403 ·Status: NOT_YET_RECRUITING
-
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
NCT06923657 ·Status: RECRUITING ·Phase: NA
-
Verification of Shear Wave Elastography for DEtection of Prostate Cancer
NCT04836949 ·Status: UNKNOWN ·Phase: NA
-
a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy
NCT05670691 ·Status: UNKNOWN
-
Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model
NCT05587192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450435 ·Status: COMPLETED
-
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482645 ·Status: RECRUITING ·Phase: NA
-
Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer
NCT07489729 ·Status: COMPLETED ·Phase: NA
-
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
NCT06126172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy
NCT05179720 ·Status: UNKNOWN ·Phase: NA
-
Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.
NCT02739048 ·Status: UNKNOWN
-
Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients
NCT01401972 ·Status: COMPLETED
-
Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies.
NCT01455792 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482658 ·Status: COMPLETED ·Phase: NA
-
A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer
NCT05073653 ·Status: UNKNOWN ·Phase: NA
-
FFOCT for the Diagnosis of Prostate Cancer
NCT02394223 ·Status: COMPLETED
-
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
NCT06507462 ·Status: COMPLETED
-
High-intensity Focused Ultrasound Study
NCT03927924 ·Status: TERMINATED ·Phase: NA
-
Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections
NCT03496142 ·Status: UNKNOWN ·Phase: NA
-
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy
NCT04271527 ·Status: RECRUITING ·Phase: NA
-
Targeted Biopsy, Rapid Pathology, and Immediate Surgery in USTC High-Risk Prostate Cancer: A Prospective Multicenter Study
NCT07709338 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk
NCT06494696 ·Status: RECRUITING
-
Multicenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate Cancer
NCT05854940 ·Status: UNKNOWN
-
Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy
NCT06677775 ·Status: RECRUITING